Jim Hoffman: Uncontrolled Neutrophil Activation and NET Release in the Vasculature
Jim Hoffman, Former Technical Advisor at Cygnus Technologies, LLC, posted on LinkedIn:
” ‘We observe extensive spontaneous neutrophil extracellular trap (NET) formation in MIS-C, and we identify neutrophil activation and degranulation signatures. Mechanistically, we determine that SARS-CoV-2 immune complexes are sufficient to trigger NETosis. Our findings suggest that hyperinflammatory presentation during MIS-C could be mechanistically linked to persistent SARS-CoV-2 antigenemia, driven by uncontrolled neutrophil activation and NET release in the vasculature.’ Yonker et al 2022 Neutrophil profiles of pediatric COVID-19 and multisystem inflammatory syndrome in children
Here is a extracorporeal removal therapy developed by https://santersus.com. This therapy is designed to specifically remove and treat the immunothrombotic complications resulting from LC and many other disease triggers worsened by having too many hyperactivated neutrophils/NETs circulating in the blood. Read more here.
Directly targeting the removal of NETs from plasma is proving powerful for the treatment of severe drug-refractory SLE. What about other hyperactivated NETotic-driven diseases like LC PASC/MIS-C or A that display chronic low to intermediate grade NETosis dysregulation?
Your findings of hyperactivated NETosis induction and poor NET clearance are not unique. For more research, visit here.”
Quoting PolyBio Research Foundation’s post:
“PolyBio supports research & treatment for children with Long COVID. This year, a study by our team at Harvard Medical School found that neutrophil immune cells from children with Long Covid were hyperactive and associated with pro-inflammatory pathway signaling.
Circulating spike protein, potentially leaking from SARS-CoV-2 tissue reservoirs, was detected in blood from a subset of children. We are further supporting a clinical trial in Long COVID children, to test if the drug Larazotide can reduce gut barrier permeability, thereby stopping spike leakage into blood.
Learn more about the research that PolyBio is driving forward in our Impact Report”
Get informed with Hemostasis Today.
-
May 28, 2026, 16:11Laura Dormer: Real-World Safety of DOACs vs LMWH in Cancer-Associated VTE Acroos Europe
-
May 28, 2026, 16:08Esau Martinez Ruiz: Proud to be Part of the Faculty at BDFLOW Summit26 in Brussels
-
May 28, 2026, 16:06Francisco Chacon-Lozsan: Why Anticoagulation in the ICU is not One Protocol?
-
May 28, 2026, 16:04When was the Last Time You Had Your Cholesterol Checked? – UNC Health
-
May 28, 2026, 16:03Paul Bolaji: ACTIVATE Study in Ghana Demonstrates Over 400% Increase in Stroke Thrombolysis
-
May 28, 2026, 15:57Lysanne van der Wal – Smit: Improving Care for Women Affected by HG at ICHG 2026
-
May 28, 2026, 15:50Marieke Verweij: Long Term Impact of Pulmonary Embolism in Children and Adolescents
-
May 28, 2026, 15:47Lee Peter Bee: A 2025 Proof of Concept – Hybrid Heart
-
May 28, 2026, 15:47Mathangi Kumar: Comprehensive Multidisciplinary Care Improves Dental Outcomes in People With Haemophilia